AbbVie (ABBV)
$90.05
0.06 (0.07%)
ABBV Stock Quote Delayed 30 Minutes
Previous Close
$90.11
Market Cap
142.90B
PE Ratio
22.63
EPS
3.98
Volume (Avg. Vol.)
502
Day's Range
90.11 - 90.11
52-Week Range
62.55 - 101.28
Dividend & Yield
3.59 (3.99%)
ABBV Stock Predictions, Articles, and AbbVie News
Great Yield and Packed Pipeline Signal a Buy for AbbVie
Investors can still own AbbVie stock at a good price, even in the wake of a potentially lifesaving collaboration.
AbbVie Earnings: ABBV Stock Drops 2% Despite Q2 Beats
AbbVie earnings on Friday have ABBV stock slighty lower despite the company beating EPS and revenue estimates from Wall Street.
The 8 Most Reliable Blue-Chip Stocks In the Market Today
Fortunately, with these strong blue-chip stocks, buying safety doesn’t mean you’re going to miss out on growth. Here's why.
AbbVie Remains One of the Safest Pharma Investments You Can Make
The pharmaceutical market has its ups and downs, but that doesn't mean every investment is risky as ABBV stock is a reasonably safe bet.
4 Top Stock Trades for Wednesday: LVGO, WMT, ABBV, NVAX
AbbVie, Livongo, Walmart and Novavax were our top stock trades for Wednesday. That said, let's look at the charts to see what's going on.
AbbVie Stands to Benefit from Affluenza
With another wave of coronavirus cases hitting the U.S., AbbVie stock seems a dubious investment. Yet with the acquisition of Allergan and its Botox treatment, ABBV has long-term upside potential.
AbbVie Is Cheap and Pays an Attractive Yield
AbbVie stock is both cheap and has an attractive dividend yield. AbbVie stock sells below 10x earnings, with a 4.9% dividend yield and a 28% upside target value.
Abbvie Stock is Offering Investors an Oil Yield Without Oil’s Risk
Analysts call ABBV stock a bargain after its $63 billion purchase of Allergan, whose existing drugs and pipeline are now expected to replace revenue from Humira.
AbbVie Will Be in Big Trouble When Its Patent Cliff Arrives
ABBV stock may seem like an attractive value name. But while it is very profitable now, things are set to worsen dramatically in a few years..
AbbVie Stock Is More Than a Great Dividend Payer
It's fine if you want to hold ABBV stock for the dividend payouts, but there are also other reasons to own it.
AbbVie Stock Is a Winner in the Pharmaceutical Industry
The public health crisis threw AbbVie into the spotlight but the company handled the ongoing crisis better than its competitors. With a successful acquisition and a high dividend yield. ABBV stock is a safe bet for investors in a volatile market.
AbbVie Is More Than Just a Portfolio of Drugs and Acquisitions
With AbbVie's buyout of Allergan officially finalized, ABBV stock has moved significantly higher since then. However, ABBV is so much more than this headline event.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
